Sarah Spencer
Investor Relations Contact bij VOR BIOPHARMA INC.
Actieve functies van Sarah Spencer
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| VOR BIOPHARMA INC. | Investor Relations Contact | - | - |
| Public Communications Contact | - | - |
Loopbaan van Sarah Spencer
Eerdere bekende functies van Sarah Spencer
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| AUDENTES THERAPEUTICS, INC. | Public Communications Contact | 01-04-2019 | 01-04-2021 |
| GSK PLC | Public Communications Contact | - | - |
Opleiding van Sarah Spencer
| State University of New York at Buffalo | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 4 |
| Verenigd Koninkrijk | 2 |
Operationeel
| Public Communications Contact | 3 |
| Undergraduate Degree | 1 |
| Investor Relations Contact | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| GSK PLC | Health Technology |
| VOR BIOPHARMA INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Astellas Gene Therapies, Inc.
 Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Astellas Gene Therapies, Inc. is a biotechnology company, which engages in the development and commercialization of gene therapy products for patients with serious and rare diseases caused by single gene defects. The company was founded by Matthew R. Patterson and Thomas J. Schuetz on November 13, 2012 and is headquartered in San Francisco, CA. | Health Technology |
- Beurs
- Insiders
- Sarah Spencer
- Ervaring
